Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2008 Apr 30:8:32.
doi: 10.1186/1471-244X-8-32.

Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia

Gunnar Morken  1 , Jan H Widen, Rolf W Grawe
Affiliations
Multicenter Study

Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia

Gunnar Morken et al. BMC Psychiatry. .

Abstract

Background: The aims of this study were to describe outcome with respect to persistent psychotic symptoms, relapse of positive symptoms, hospital admissions, and application of treatment by coercion among patients with recent onset schizophrenia being adherent and non-adherent to anti-psychotic medication.

Materials and methods: The study included 50 patients with recent onset schizophrenia, schizoaffective or schizophreniform disorders. The patients were clinically stable at study entry and had less than 2 years duration of psychotic symptoms. Good adherence to antipsychotic medication was defined as less than one month without medication. Outcomes for poor and good adherence were compared over a 24-month follow-up period.

Results: The Odds Ratio (OR) of having a psychotic relapse was 10.27 and the OR of being admitted to hospital was 4.00 among non-adherent patients. Use of depot-antipsychotics were associated with relapses (OR = 6.44).

Conclusion: Non-adherence was associated with relapse, hospital admission and having persistent psychotic symptoms. Interventions to increase adherence are needed.

Trial registration: Current Controlled Trials NCT00184509. Key words: Adherence, schizophrenia, antipsychotic medication, admittances, relapse.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WYATT RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull. 1991;17:325–351. - PubMed
    1. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL, Jr, Davis JM, Lewis DA. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry. 1995;152:856–861. - PubMed
    1. Sullivan G, Wells KB, Morgenstern H, Leake B. Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi. Am J Psychiatry. 1995;152:1749–1756. - PubMed
    1. Ayuso-Gutierrez JL, del Rio V. Factors influencing relapse in the long-term course of schizophrenia. Schizophr Res. 1997;28:199–206. doi: 10.1016/S0920-9964(97)00131-X. - DOI - PubMed
    1. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004;161:692–699. doi: 10.1176/appi.ajp.161.4.692. - DOI - PubMed

Publication types

Substances

Associated data